Quick Answer
iBio, Inc. reported Gross Profit of $2.17 million for fiscal year 2022.
iBio, Inc. Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2022 | $2.17M | +138.4% |
| 2021 | $909.0K | -2.8% |
| 2020 | $935.0K | — |
Quarterly Gross Profit
| Quarter Ending | Gross Profit | YoY | QoQ |
|---|---|---|---|
| March 31, 2022 | $1.90M | +596.7% | +3345.5% |
| December 31, 2021 | $55.0K | -88.9% | -67.8% |
| September 30, 2021 | $171.0K | -43.6% | -37.1% |
| March 31, 2021 | $272.0K | +2620.0% | -44.9% |
| December 31, 2020 | $494.0K | — | +63.0% |
| September 30, 2020 | $303.0K | — | +2930.0% |
| March 31, 2020 | $10.0K | — | — |
- iBio, Inc. showed an increase of +138.4% in Gross Profit compared to the prior fiscal year.
- Over the 2020–2022 period, iBio, Inc.’s gross profit has grown by 131.8% (from $935.0 thousand to $2.17 million).
- The most recent figure is from iBio, Inc.’s fiscal year 2022 report (Form 10-K), filed with the SEC on October 11, 2022.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: